There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for Ensysce Biosciences Inc. (ENSC) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by +$0.0014, or +0.59%, to $0.239. Volume reached 24,970 shares, with price reaching a high of $0.2413 and a low of $0.22. The stock was recently discussed on Yahoo Finance as it revealed that Ensysce Biosciences Announces Initiation of Second Human Abuse Potential Study, Being Conducted by DVCR.
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $0.22 and fluctuated between $0.2330 as its day high and $0.1920 as its day low. The current market capitalization of Ensysce Biosciences Inc. is $5.49M. A total of 1.14 million shares were traded on the day, compared to an average of 1.63M shares.
Insider trades can also provide insight into a stock’s future direction. During the recent three months, ENSC has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 2 BUYs and 0 SELLs from insiders. Insiders purchased 97,000 shares during that period but sold 0.
In the most recent transaction, Kirkpatrick Lynn bought 27,000 shares of ENSC for 0.53 per share on May 26. After the transaction, the Chief Executive Officer now owns 381,851 company shares. In a previous transaction on May 25, Kirkpatrick Lynn bought 70,000 shares at 0.49 per share. ENSC shares that Chief Executive Officer owns now total 354,851.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for ENSC in the last 3 months, the mean price target is $4.00 with high estimates of $4.00 and low estimates of $4.00. In terms of 52-week highs and lows, ENSC has a high of $7.00 and a low of $0.23.
As of this writing, ENSC has an earnings estimate of $-0.15 per share for the current quarter. EPS was calculated based on a consensus of 1 estimates, with a high estimate of $-0.15 per share and a lower estimate of $-0.15. The company reported an EPS of $-0.24 in the last quarter, which was -14.29% lower than expectations of $-0.21.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 1 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ENSC is Buy with a score of 5.00. A total of 1 analysts rated the stock as Buy while 0 rated it as Overweight while 0 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.